What is 10x Genomics, Inc.'s free cash flow yield?

10x Genomics, Inc. (TXG) reported free cash flow yield of 4.5% in Q1 2026.

What is the long-term trend for 10x Genomics, Inc.'s free cash flow yield?

Over 3 years (2020 to 2025), 10x Genomics, Inc.'s free cash flow yield has grown at a 57.6% compound annual growth rate (CAGR), from -1.6% to 6.3%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

10x Genomics, Inc. TXG Free cash flow yield

Free cash flow yield at other companies

TEC

Bio-TechneTECH

3.3%+0.9pp

BrukerBRKR

0.9%-1.8pp

IlluminaILMN

5.2%-1.8pp

Twist Bioscience CorporationTWST

-3.3%+0.7pp

RevvityRVTY

5%+0.9pp

Bio-Rad LaboratoriesBIO

4.7%-0.5pp

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

free cash flow/market cap=4.5%

Based on trailing twelve months.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s free cash flow yield?: 10x Genomics, Inc. (TXG) reported free cash flow yield of 4.5% in Q1 2026.
What is the long-term trend for 10x Genomics, Inc.'s free cash flow yield?: Over 3 years (2020 to 2025), 10x Genomics, Inc.'s free cash flow yield has grown at a 57.6% compound annual growth rate (CAGR), from -1.6% to 6.3%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.